Medartis Holding AG (XSWX:MED) Beneish M-Score: -2.11 (As of Jun. 25, 2026)


XSWX:MED Medartis Holding AG XSWX:MED
76 GF Score
Price CHF72.00
GF Value CHF105.61
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Medartis Holding AG Beneish M-Score?

Medartis Holding AG XSWX:MED -0.55% 76 Beneish M-Score is -2.11 as of Jun. 25, 2026. GuruFocus rates XSWX:MED with a GF Score™ of 76/100 and a GF Value™ of CHF105.61 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 766 Medical Devices & Instruments companies, Medartis Holding AG ranks worse than 77.15% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.11 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Medartis Holding AG's Beneish M-Score or its related term are showing as below:

XSWX:MED' s Beneish M-Score Range Over the Past 10 Years
Min: -3.18   Med: -2.61   Max: -2.01
Current: -2.11

During the past 12 years, the highest Beneish M-Score of Medartis Holding AG was -2.01. The lowest was -3.18. And the median was -2.61.


Medartis Holding AG Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Medartis Holding AG's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medartis Holding AG Beneish M-Score Chart

Medartis Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.41 -2.01 -2.65 -3.18 -2.11

Medartis Holding AG Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.65 0.00 -3.18 0.00 -2.11

XSWX:MED vs ABT, SYK, MDT: Beneish M-Score Comparison

For the Medical Devices subindustry, Medartis Holding AG's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medartis Holding AG Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medartis Holding AG's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Medartis Holding AG's Beneish M-Score falls into.


XSWX:MED
76GF Score
Medartis Holding AG XSWX:MED
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medartis Holding AG Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Medartis Holding AG for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0655+0.528 * 1.0473+0.404 * 1.8827+0.892 * 1.1976+0.115 * 1.0658
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0265+4.679 * -0.047271-0.327 * 1.0975
=-2.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was CHF59.0 Mil.
Revenue was CHF269.3 Mil.
Gross Profit was CHF204.3 Mil.
Total Current Assets was CHF195.3 Mil.
Total Assets was CHF559.9 Mil.
Property, Plant and Equipment(Net PPE) was CHF94.1 Mil.
Depreciation, Depletion and Amortization(DDA) was CHF25.5 Mil.
Selling, General, & Admin. Expense(SGA) was CHF172.7 Mil.
Total Current Liabilities was CHF88.2 Mil.
Long-Term Debt & Capital Lease Obligation was CHF131.5 Mil.
Net Income was CHF8.3 Mil.
Gross Profit was CHF0.0 Mil.
Cash Flow from Operations was CHF34.8 Mil.
Total Receivables was CHF46.2 Mil.
Revenue was CHF224.8 Mil.
Gross Profit was CHF178.7 Mil.
Total Current Assets was CHF265.9 Mil.
Total Assets was CHF460.0 Mil.
Property, Plant and Equipment(Net PPE) was CHF76.0 Mil.
Depreciation, Depletion and Amortization(DDA) was CHF22.3 Mil.
Selling, General, & Admin. Expense(SGA) was CHF140.5 Mil.
Total Current Liabilities was CHF51.0 Mil.
Long-Term Debt & Capital Lease Obligation was CHF113.4 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(58.977 / 269.257) / (46.219 / 224.831)
=0.219036 / 0.205572
=1.0655

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(178.683 / 224.831) / (204.33 / 269.257)
=0.794744 / 0.758866
=1.0473

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (195.282 + 94.059) / 559.922) / (1 - (265.945 + 75.952) / 459.961)
=0.483248 / 0.256683
=1.8827

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=269.257 / 224.831
=1.1976

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(22.3 / (22.3 + 75.952)) / (25.451 / (25.451 + 94.059))
=0.226967 / 0.212961
=1.0658

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(172.724 / 269.257) / (140.505 / 224.831)
=0.641484 / 0.624936
=1.0265

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((131.542 + 88.173) / 559.922) / ((113.443 + 51.018) / 459.961)
=0.392403 / 0.357554
=1.0975

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(8.349 - 0 - 34.817) / 559.922
=-0.047271

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Medartis Holding AG has a M-score of -2.11 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.11 mean?
Medartis Holding AG (XSWX:MED) has a Beneish M-Score of -2.11 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Medartis Holding AG and its competitors. According to the industry distribution chart, Medartis Holding AG ranks #591 out of 766 companies in the Medical Devices & Instruments industry, placing it in the top 77.2%.
Is Medartis Holding AG's Beneish M-Score too high?
Medartis Holding AG's current Beneish M-Score is -2.11. Based on the distribution chart, Medartis Holding AG ranks #591 out of 766 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medartis Holding AG has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's Beneish M-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medartis Holding AG ranks #591 out of 766 companies for Beneish M-Score. This places Medartis Holding AG in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Medartis Holding AG and its competitors. Medartis Holding AG's current Beneish M-Score is -2.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF105.61, compared to a current price of CHF72.00 — trading 31.8% below its estimated fair value. The current Beneish M-Score is -2.11. Medartis Holding AG's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current Beneish M-Score is -2.11 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?

Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued. The current stock price of CHF72.00 is trading 31.8% below its estimated GF Value™ of CHF105.61. GuruFocus considers Medartis Holding AG to be Significantly Undervalued.

Key valuation signals for XSWX:MED:

  • Beneish M-Score: -2.11
  • GF Value™: CHF105.61 vs. price of CHF72.00 (31.8% below fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medartis Holding AG Business Description

Other Exchanges MEDz:UK1RU:Germany
Address Hochbergerstrasse 60E, Basel, CHE, 4057
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
76GF Score

Get the complete analysis for XSWX:MED

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF72.00
Price
CHF105.61
GF Value